n-3 PUFAs favour immunity and lessen inflammation in patients undergoing surgery for GI cancer

  • 07/05/2017

Surgical resection is the principal treatment in early stages of gastro-intestinal (GI) cancer, but involves the risk of developing several complications, including malnutrition, tumour-induced immunosuppression, surgical stress and inflammation.

Read more

Prevention of postoperative complications in colorectal cancer

  • 02/08/2017

Worldwide, colorectal cancer (CRC) is the third most frequent cancer in men, the second most common in women and the fourth leading cause of cancer-related death.

Read more

Docosahexaenoic acid (DHA) epoxy metabolites inhibit angiogenesis, tumour growth and metastasis

  • 05/31/2013

A study by Zhang G. et al.

Read more

Diet can affect prostate cancer

  • 12/09/2013

William Aronson and his team, researchers at the University of California Los Angeles (UCLA), have undertaken a thorough study of the relationship between prostate cancer and fatty acids.

Read more

EPA and DHA in the gastrointestinal cancers

  • 12/17/2014

Research into the use of the omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) anddocosahexaenoic acid (DHA) in the prevention and treatment of cancer shows that omega-3 may exert anti-carcinogenic actions by influencing the proces

Read more

Breast cancer: EPA, DHA, chemotherapy and antioxidants

  • 07/23/2015

The role of nutrition in preventing cancer is sufficiently well established. Dietary agents have been shown to suppress transformative, hyperproliferative and inflammatory processes that initiate carcinogenesis.

Read more